Christian Morsczeck

Prof. Dr. Christian Morsczeck

Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2008 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
CMChristian Morsczeck
Christian Morsczeck
GSGottfried Schmalz
Gottfried Schmalz
TRTorsten Eugen Reichert
Torsten Eugen Reichert
FVFlorian Völlner
Florian Völlner
KGKerstin Galler
Kerstin Galler
ODOliver Driemel
Oliver Driemel

15 November 2017 in Expert Opinion on Biological Therapy
Verified
Journal Article
Closed access
CMChristian Morsczeck
Christian Morsczeck
TRTorsten E. Reichert
Torsten E. Reichert
Introduction: Human dental stem cells can be obtained from postnatal teeth, extracted wisdom teeth or exfoliated deciduous teeth. Due to their differentiation potential, these mesenchymal stem cells are promising for tooth repair. Therefore, the development of dental tissue regeneration represents a suitable but challenging, target for dental stem cell therapies. Areas covered: In this review, the authors provide an overview of human dental stem cells and their properties for regeneration medicine. Numerous preclinical studies have shown that dental stem cells improve bone augmentation and healing of periodontal diseases. Clinical trials are ongoing to validate the clinical feasibility of these approaches. Dental stem cells are also important for basic research. Expert opinion: Dental stem cells offer numerous advantages for tooth repair and regeneration. Data obtained from different studies are encouraging. In the next few years, investigations on dental stem cells in basic research, pre-clinical research and clinical studies will pave the way to optimizing patient-tailored treatments for repair and regeneration of dental tissues.

10 July 2009 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
CMChristian Morsczeck
Christian Morsczeck
FVFlorian Völlner
Florian Völlner
MSMichael Saugspier
Michael Saugspier
Caroline BrandlCaroline Brandl
Caroline Brandl
TRTorsten Eugen Reichert
Torsten Eugen Reichert
GSGottfried Schmalz
Gottfried Schmalz

28 February 2009 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
CMChristian Morsczeck
Christian Morsczeck
GSGottfried Schmalz
Gottfried Schmalz
TRTorsten Eugen Reichert
Torsten Eugen Reichert
FVFlorian Völlner
Florian Völlner
MSMichael Saugspier
Michael Saugspier
ODOliver Driemel
Oliver Driemel

20 July 2012 in Stem Cells and Development
Verified
Journal Article
Closed access
SVSandra Viale-Bouroncle
Sandra Viale-Bouroncle
OFOliver Felthaus
Oliver Felthaus
GSGottfried Schmalz
Gottfried Schmalz
GBGero Brockhoff
Gero Brockhoff
TRTorsten E Reichert
Torsten E Reichert
CMChristian Morsczeck
Christian Morsczeck
The transcription factor DLX3 plays a decisive role in bone development of vertebrates. In neural-crest derived stem cells from the dental follicle (DFCs), DLX3 is differentially expressed during osteogenic differentiation, while other osteogenic transcription factors such as DLX5 or RUNX2 are not highly induced. DLX3 has therefore a decisive role in the differentiation of DFCs, but its actual biological effects and regulation are unknown. This study investigated the DLX3-regulated processes in DFCs. After DLX3 overexpression, DFCs acquired a spindle-like cell shape with reorganized actin filaments. Here, marker genes for cell morphology, proliferation, apoptosis, and osteogenic differentiation were significantly regulated as shown in a microarray analysis. Further experiments showed that DFCs viability is directly influenced by the expression of DLX3, for example, the amount of apoptotic cells was increased after DLX3 silencing. This transcription factor stimulates the osteogenic differentiation of DFCs and regulates the BMP/SMAD1-pathway. Interestingly, BMP2 did highly induce DLX3 and reverse the inhibitory effect of DLX3 silencing in osteogenic differentiation. However, after DLX3 overexpression in DFCs, a BMP2 supplementation did not improve the expression of DLX3 and the osteogenic differentiation. In conclusion, DLX3 influences cell viability and regulates osteogenic differentiation of DFCs via a BMP2-dependent pathway and a feedback control.

17 January 2019 in Archives of Oral Biology
Verified
Journal Article
Closed access
CMChristian Morsczeck
Christian Morsczeck